comparemela.com

Latest Breaking News On - மெர்க் ப்ரெஸ் வெளியீடுகள் - Page 1 : comparemela.com

Redirecting to Merck Announces Appointment of Head of China & International for Healthcare

Merck Announces Appointment of Head of China & International for Healthcare Merck, a leading science and technology company, today announced that Hong Chow will join its Healthcare business sector as Head of China & International on October 1. In this role at Merck, Chow will lead China, Japan as well the regions Europe, Latin America, Asia-Pacific and Middle East, Africa and Russia, the franchise of Cardiovascular Metabolism & Endocrinology (CM&E), and the Global Business Innovation team. Chow will report to Peter Guenter, Member of the Executive Board of Merck and CEO Healthcare. She will serve as a member of the Healthcare Executive Committee, and be based in Shanghai, China.

Merck Announces Appointment of Head of China & International for Healthcare

Merck Announces Appointment of Head of China & International for Healthcare
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Merck Celebrates Key Milestone in Construction of Biotech Development Center in Switzerland

Merck Celebrates Key Milestone in Construction of Biotech Development Center in Switzerland
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Data from Merck s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21

Data from Merck’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21 Saturday, May 22, 2021 12:20PM IST (6:50AM GMT)   New analyses from pivotal BAVENCIO ® study reinforce unique clinical benefits across different subgroups in the treatment of advanced urothelial carcinoma New data from VISION study of TEPMETKO ® show association between liquid biopsy-identified biomarker and clinical response in METex14 skipping NSCLC, supporting liquid biopsy as a means for monitoring treatment response TEPMETKO Oral presentations from independent studies reinforce the position of ERBITUX ® in 1L RAS wt mCRC and as backbone of treatment in SCCHN   Not intended for UK-, US- or Canada-based media

Data from Merck s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21

Data from Merck s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.